{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:16:47Z","timestamp":1795047407130,"version":"4.10.2"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The androgen receptor (AR) is a critical driver of prostate cancer (PCa). Here, to study regulators of AR protein levels and oncogenic activity, we developed a live-cell quantitative endogenous AR fluorescent reporter. Leveraging this AR reporter, we performed genome-scale CRISPRi flow cytometry sorting screens to systematically identify genes that modulate AR protein levels. We identified and validated known AR protein regulators, including HOXB13 and GATA2, and also unexpected top hits including PTGES3\u2014a poorly characterized gene in PCa. PTGES3 repression resulted in loss of AR protein, cell-cycle arrest and cell death in AR-driven PCa models. Clinically, analysis of PCa data demonstrates that PTGES3 expression is associated with AR-directed therapy resistance. Mechanistically, we show PTGES3 binds directly to AR, regulates AR protein stability and is necessary for AR function in the nucleus at AR target genes. PTGES3 represents a potential therapeutic target for overcoming known mechanisms of resistance to existing AR-directed therapies in PCa.<\/jats:p>","DOI":"10.1038\/s41588-025-02388-8","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:03:08Z","timestamp":1762336988000},"page":"3027-3038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8628-9698","authenticated-orcid":false,"given":"Haolong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Melnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky Xu Hua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1144-1413","authenticated-orcid":false,"given":"Raunak","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1042-6294","authenticated-orcid":false,"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2629-9966","authenticated-orcid":false,"given":"Martin","family":"Sj\u00f6str\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7791-7206","authenticated-orcid":false,"given":"Jasmine A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2173-3647","authenticated-orcid":false,"given":"Wanting","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa N.","family":"Chesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8058-1033","authenticated-orcid":false,"given":"Tatyanah","family":"Farsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto J.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8362-1165","authenticated-orcid":false,"given":"Seema","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1258-0391","authenticated-orcid":false,"given":"Jonathan","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajdeep","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Egusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Kishishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhilash","family":"Barpanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7107-0933","authenticated-orcid":false,"given":"Ashutosh","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8405-3035","authenticated-orcid":false,"given":"Mohammed","family":"Alshalalfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Winters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie T.","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elai","family":"Davicioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7465-6964","authenticated-orcid":false,"given":"Arun P.","family":"Wiita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Stohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1704-4141","authenticated-orcid":false,"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3191-6268","authenticated-orcid":false,"given":"Eric J.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevan M.","family":"Shokat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5451-5726","authenticated-orcid":false,"given":"Peter S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4726-1473","authenticated-orcid":false,"given":"David A.","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth V.","family":"Wasmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5854-0825","authenticated-orcid":false,"given":"Luke A.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0963-7687","authenticated-orcid":false,"given":"Felix Y.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"2388_CR1","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson, D. et al. Integrative clinical genomics of advanced prostate cancer. Cell 161, 1215\u20131228 (2015).","journal-title":"Cell"},{"key":"2388_CR2","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","volume":"174","author":"DA Quigley","year":"2018","unstructured":"Quigley, D. A. et al. Genomic hallmarks and structural variation in metastatic prostate cancer. Cell 174, 758\u2013769 (2018).","journal-title":"Cell"},{"key":"2388_CR3","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1158\/0008-5472.CAN-08-3667","volume":"69","author":"G Attard","year":"2009","unstructured":"Attard, G. et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res. 69, 2912\u20132918 (2009).","journal-title":"Cancer Res."},{"key":"2388_CR4","first-page":"735","volume":"144","author":"JA Ruizeveld de Winter","year":"1994","unstructured":"Ruizeveld de Winter, J. A. et al. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am. J. Pathol. 144, 735\u2013746 (1994).","journal-title":"Am. J. Pathol."},{"key":"2388_CR5","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1002\/1097-0142(19910615)67:12<3057::AID-CNCR2820671221>3.0.CO;2-S","volume":"67","author":"MV Sadi","year":"1991","unstructured":"Sadi, M. V., Walsh, P. C. & Barrack, E. R. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer 67, 3057\u20133064 (1991).","journal-title":"Cancer"},{"key":"2388_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10555-013-9474-0","volume":"33","author":"Z Culig","year":"2014","unstructured":"Culig, Z. & Santer, F. R. Androgen receptor signaling in prostate cancer. Cancer Metastasis Rev. 33, 413\u2013427 (2014).","journal-title":"Cancer Metastasis Rev."},{"key":"2388_CR7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/ng.3419","volume":"47","author":"MM Pomerantz","year":"2015","unstructured":"Pomerantz, M. M. et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat. Genet. 47, 1346\u20131351 (2015).","journal-title":"Nat. Genet."},{"key":"2388_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41586-019-1347-4","volume":"571","author":"A Parolia","year":"2019","unstructured":"Parolia, A. et al. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer. Nature 571, 413\u2013418 (2019).","journal-title":"Nature"},{"key":"2388_CR9","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1715546","volume":"378","author":"MR Smith","year":"2018","unstructured":"Smith, M. R. et al. Apalutamide treatment and metastasis-free survival in prostate cancer. N. Engl. J. Med. 378, 1408\u20131418 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2388_CR10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1056\/NEJMoa1405095","volume":"371","author":"TM Beer","year":"2014","unstructured":"Beer, T. M. et al. Enzalutamide in metastatic prostate cancer before chemotherapy. N. Engl. J. Med. 371, 424\u2013433 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2388_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa1209096","volume":"368","author":"CJ Ryan","year":"2013","unstructured":"Ryan, C. J. et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. N. Engl. J. Med. 368, 138\u2013148 (2013).","journal-title":"N. Engl. J. Med."},{"key":"2388_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","volume":"360","author":"M Bolla","year":"2002","unstructured":"Bolla, M. et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360, 103\u2013106 (2002).","journal-title":"Lancet"},{"key":"2388_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1607529","volume":"376","author":"WU Shipley","year":"2017","unstructured":"Shipley, W. U. et al. Radiation with or without antiandrogen therapy in recurrent prostate cancer. N. Engl. J. Med. 376, 417\u2013428 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2388_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1903307","volume":"381","author":"KN Chi","year":"2019","unstructured":"Chi, K. N. et al. Apalutamide for metastatic, castration-sensitive prostate cancer. N. Engl. J. Med. 381, 13\u201324 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2388_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1056\/NEJMoa1903835","volume":"381","author":"ID Davis","year":"2019","unstructured":"Davis, I. D. et al. Enzalutamide with standard first-line therapy in metastatic prostate cancer. N. Engl. J. Med. 381, 121\u2013131 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2388_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJMoa1702900","volume":"377","author":"ND James","year":"2017","unstructured":"James, N. D. et al. Abiraterone for prostate cancer not previously treated with hormone therapy. N. Engl. J. Med. 377, 338\u2013351 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2388_CR17","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1056\/NEJMoa2003892","volume":"382","author":"CN Sternberg","year":"2020","unstructured":"Sternberg, C. N. et al. Enzalutamide and survival in nonmetastatic, castration-resistant prostate cancer. N. Engl. J. Med. 382, 2197\u20132206 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2388_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1056\/NEJMoa1815671","volume":"380","author":"K Fizazi","year":"2019","unstructured":"Fizazi, K. et al. Darolutamide in nonmetastatic, castration-resistant prostate cancer. N. Engl. J. Med. 380, 1235\u20131246 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2388_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","volume":"15","author":"PA Watson","year":"2015","unstructured":"Watson, P. A., Arora, V. K. & Sawyers, C. L. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat. Rev. Cancer 15, 701\u2013711 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"2388_CR20","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","volume":"36","author":"R Aggarwal","year":"2018","unstructured":"Aggarwal, R. et al. Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study. J. Clin. Oncol. 36, 2492\u20132503 (2018).","journal-title":"J. Clin. Oncol."},{"key":"2388_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2017.09.003","volume":"32","author":"EG Bluemn","year":"2017","unstructured":"Bluemn, E. G. et al. Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling. Cancer Cell 32, 474\u2013489 (2017).","journal-title":"Cancer Cell"},{"key":"2388_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/ng0495-401","volume":"9","author":"T Visakorpi","year":"1995","unstructured":"Visakorpi, T. et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat. Genet. 9, 401\u2013406 (1995).","journal-title":"Nat. Genet."},{"key":"2388_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso, C. S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239\u2013243 (2012).","journal-title":"Nature"},{"key":"2388_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cell.2018.05.037","volume":"174","author":"DY Takeda","year":"2018","unstructured":"Takeda, D. Y. et al. A somatically acquired enhancer of the androgen receptor is a noncoding driver in advanced prostate cancer. Cell 174, 422\u2013432 (2018).","journal-title":"Cell"},{"key":"2388_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2018.05.036","volume":"174","author":"SR Viswanathan","year":"2018","unstructured":"Viswanathan, S. R. et al. Structural alterations driving castration-resistant prostate cancer revealed by linked-read genome sequencing. Cell 174, 433\u2013447 (2018).","journal-title":"Cell"},{"key":"2388_CR26","first-page":"2892","volume":"61","author":"CW Gregory","year":"2001","unstructured":"Gregory, C. W., Johnson, R. T., Mohler, J. L., French, F. S. & Wilson, E. M. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res. 61, 2892\u20132898 (2001).","journal-title":"Cancer Res."},{"key":"2388_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13668","volume":"7","author":"C Henzler","year":"2016","unstructured":"Henzler, C. et al. Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer. Nat. Commun. 7, 13668 (2016).","journal-title":"Nat. Commun."},{"key":"2388_CR28","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1158\/0008-5472.CAN-08-0594","volume":"68","author":"SM Dehm","year":"2008","unstructured":"Dehm, S. M., Schmidt, L. J., Heemers, H. V., Vessella, R. L. & Tindall, D. J. Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Cancer Res. 68, 5469\u20135477 (2008).","journal-title":"Cancer Res."},{"key":"2388_CR29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.cell.2013.07.029","volume":"154","author":"K-H Chang","year":"2013","unstructured":"Chang, K.-H. et al. A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer. Cell 154, 1074\u20131084 (2013).","journal-title":"Cell"},{"key":"2388_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nbt1044","volume":"23","author":"S Cabantous","year":"2005","unstructured":"Cabantous, S., Terwilliger, T. C. & Waldo, G. S. Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein. Nat. Biotechnol. 23, 102\u2013107 (2005).","journal-title":"Nat. Biotechnol."},{"key":"2388_CR31","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/10904","volume":"17","author":"GS Waldo","year":"1999","unstructured":"Waldo, G. S., Standish, B. M., Berendzen, J. & Terwilliger, T. C. Rapid protein-folding assay using green fluorescent protein. Nat. Biotechnol. 17, 691\u2013695 (1999).","journal-title":"Nat. Biotechnol."},{"key":"2388_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11046","volume":"7","author":"D Kamiyama","year":"2016","unstructured":"Kamiyama, D. et al. Versatile protein tagging in cells with split fluorescent protein. Nat. Commun. 7, 11046 (2016).","journal-title":"Nat. Commun."},{"key":"2388_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00494-8","volume":"8","author":"S Feng","year":"2017","unstructured":"Feng, S. et al. Improved split fluorescent proteins for endogenous protein labeling. Nat. Commun. 8, 370 (2017).","journal-title":"Nat. Commun."},{"key":"2388_CR34","doi-asserted-by":"publisher","first-page":"E3501","DOI":"10.1073\/pnas.1606731113","volume":"113","author":"MD Leonetti","year":"2016","unstructured":"Leonetti, M. D., Sekine, S., Kamiyama, D., Weissman, J. S. & Huang, B. A scalable strategy for high-throughput GFP tagging of endogenous human proteins. Proc. Natl Acad. Sci. USA 113, E3501\u2013E3508 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2388_CR35","doi-asserted-by":"publisher","first-page":"e19760","DOI":"10.7554\/eLife.19760","volume":"5","author":"MA Horlbeck","year":"2016","unstructured":"Horlbeck, M. A. et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. Elife 5, e19760 (2016).","journal-title":"Elife"},{"key":"2388_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/onc.2017.330","volume":"37","author":"S Stelloo","year":"2018","unstructured":"Stelloo, S. et al. Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis. Oncogene 37, 313\u2013322 (2018).","journal-title":"Oncogene"},{"key":"2388_CR37","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2388_CR38","doi-asserted-by":"publisher","first-page":"11878","DOI":"10.1073\/pnas.1105160108","volume":"108","author":"JT De Leon","year":"2011","unstructured":"De Leon, J. T. et al. Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells. Proc. Natl Acad. Sci. USA 108, 11878\u201311883 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2388_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11594-y","volume":"10","author":"B Eftekharzadeh","year":"2019","unstructured":"Eftekharzadeh, B. et al. Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor. Nat. Commun. 10, 3562 (2019).","journal-title":"Nat. Commun."},{"key":"2388_CR40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1210\/er.2002-0032","volume":"25","author":"CA Heinlein","year":"2004","unstructured":"Heinlein, C. A. & Chang, C. Androgen receptor in prostate cancer. Endocr. Rev. 25, 276\u2013308 (2004).","journal-title":"Endocr. Rev."},{"key":"2388_CR41","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1210\/me.2012-1056","volume":"26","author":"V Reebye","year":"2012","unstructured":"Reebye, V. et al. Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer. Mol. Endocrinol. 26, 1694\u20131706 (2012).","journal-title":"Mol. Endocrinol."},{"key":"2388_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.molonc.2014.08.014","volume":"9","author":"LQ Cano","year":"2015","unstructured":"Cano, L. Q. et al. The co-chaperone p23 promotes prostate cancer motility and metastasis. Mol. Oncol. 9, 295\u2013308 (2015).","journal-title":"Mol. Oncol."},{"key":"2388_CR43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-021-04236-1","volume":"601","author":"CM Noddings","year":"2022","unstructured":"Noddings, C. M., Wang, R. Y.-R., Johnson, J. L. & Agard, D. A. Structure of Hsp90-p23-GR reveals the Hsp90 client-remodelling mechanism. Nature 601, 465\u2013469 (2022).","journal-title":"Nature"},{"key":"2388_CR44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.molcel.2012.08.026","volume":"48","author":"E Zelin","year":"2012","unstructured":"Zelin, E., Zhang, Y., Toogun, O. A., Zhong, S. & Freeman, B. C. The p23 molecular chaperone and GCN5 acetylase jointly modulate protein-DNA dynamics and open chromatin status. Mol. Cell 48, 459\u2013470 (2012).","journal-title":"Mol. Cell"},{"key":"2388_CR45","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1126\/science.1073051","volume":"296","author":"BC Freeman","year":"2002","unstructured":"Freeman, B. C. & Yamamoto, K. R. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296, 2232\u20132235 (2002).","journal-title":"Science"},{"key":"2388_CR46","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1128\/MCB.19.5.3748","volume":"19","author":"R Knoblauch","year":"1999","unstructured":"Knoblauch, R. & Garabedian, M. J. Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction. Mol. Cell. Biol. 19, 3748\u20133759 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"2388_CR47","doi-asserted-by":"publisher","first-page":"32775","DOI":"10.1074\/jbc.M003504200","volume":"275","author":"T Tanioka","year":"2000","unstructured":"Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M. & Kudo, I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem. 275, 32775\u201332782 (2000).","journal-title":"J. Biol. Chem."},{"key":"2388_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mce.2018.07.002","volume":"489","author":"TM Penning","year":"2019","unstructured":"Penning, T. M. AKR1C3 (type 5 17\u03b2-hydroxysteroid dehydrogenase\/prostaglandin F synthase): roles in malignancy and endocrine disorders. Mol. Cell. Endocrinol. 489, 82\u201391 (2019).","journal-title":"Mol. Cell. Endocrinol."},{"key":"2388_CR49","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/ijms19020556","volume":"19","author":"KH Jeong","year":"2018","unstructured":"Jeong, K. H., Jung, J. H., Kim, J. E. & Kang, H. Prostaglandin D2-mediated DP2 and AKT signal regulate the activation of androgen receptors in human dermal papilla cells. Int. J. Mol. Sci. 19, 556 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"2388_CR50","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.molcel.2022.03.035","volume":"82","author":"EV Wasmuth","year":"2022","unstructured":"Wasmuth, E. V. et al. Allosteric interactions prime androgen receptor dimerization and activation. Mol. Cell 82, 2021\u20132031 (2022).","journal-title":"Mol. Cell"},{"key":"2388_CR51","doi-asserted-by":"publisher","first-page":"8584","DOI":"10.1073\/pnas.1922159117","volume":"117","author":"EV Wasmuth","year":"2020","unstructured":"Wasmuth, E. V. et al. Modulation of androgen receptor DNA binding activity through direct interaction with the ETS transcription factor ERG. Proc. Natl Acad. Sci. USA 117, 8584\u20138592 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2388_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07270-2","volume":"9","author":"S Stelloo","year":"2018","unstructured":"Stelloo, S. et al. Integrative epigenetic taxonomy of primary prostate cancer. Nat. Commun. 9, 4900 (2018).","journal-title":"Nat. Commun."},{"key":"2388_CR53","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564\u2013576 (2017).","journal-title":"Cell"},{"key":"2388_CR54","doi-asserted-by":"publisher","first-page":"25940","DOI":"10.1038\/s41598-024-77314-9","volume":"14","author":"AY Ge","year":"2024","unstructured":"Ge, A. Y. et al. A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation. Sci. Rep. 14, 25940 (2024).","journal-title":"Sci. Rep."},{"key":"2388_CR55","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.abl5829","volume":"378","author":"K Lou","year":"2022","unstructured":"Lou, K. et al. IFITM proteins assist cellular uptake of diverse linked chemotypes. Science 378, 1097\u20131104 (2022).","journal-title":"Science"},{"key":"2388_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaw9450","volume":"12","author":"K Lou","year":"2019","unstructured":"Lou, K. et al. KRASG12C inhibition produces a driver-limited state revealing collateral dependencies. Sci. Signal. 12, eaaw9450 (2019).","journal-title":"Sci. Signal."},{"key":"2388_CR57","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ccr.2006.09.005","volume":"10","author":"H Hieronymus","year":"2006","unstructured":"Hieronymus, H. et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 10, 321\u2013330 (2006).","journal-title":"Cancer Cell"},{"key":"2388_CR58","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","volume":"154","author":"LA Gilbert","year":"2013","unstructured":"Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442\u2013451 (2013).","journal-title":"Cell"},{"key":"2388_CR59","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-17-2745","volume":"24","author":"RJ Karnes","year":"2018","unstructured":"Karnes, R. J. et al. Development and validation of a prostate cancer genomic signature that predicts early ADT treatment response following radical prostatectomy. Clin. Cancer Res. 24, 3908\u20133916 (2018).","journal-title":"Clin. Cancer Res."},{"key":"2388_CR60","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1158\/2159-8290.CD-24-0559","volume":"15","author":"LN Chesner","year":"2025","unstructured":"Chesner, L. N. et al. Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer. Cancer Discov. 15, 481\u2013494 (2025).","journal-title":"Cancer Discov."},{"key":"2388_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"2388_CR62","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1158\/1078-0432.CCR-18-2387","volume":"25","author":"V Kothari","year":"2019","unstructured":"Kothari, V. et al. DNA-dependent protein kinase drives prostate cancer progression through transcriptional regulation of the Wnt signaling pathway. Clin. Cancer Res. 25, 5608\u20135622 (2019).","journal-title":"Clin. Cancer Res."},{"key":"2388_CR63","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nmeth.4256","volume":"14","author":"AT Kong","year":"2017","unstructured":"Kong, A. T., Leprevost, F. V., Avtonomov, D. M., Mellacheruvu, D. & Nesvizhskii, A. I. MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics. Nat. Methods 14, 513\u2013520 (2017).","journal-title":"Nat. Methods"},{"key":"2388_CR64","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1021\/acs.jproteome.2c00646","volume":"22","author":"A Barpanda","year":"2023","unstructured":"Barpanda, A. et al. Integrative proteomic and pharmacological analysis of colon cancer reveals the classical lipogenic pathway with prognostic and therapeutic opportunities. J. Proteome Res. 22, 871\u2013884 (2023).","journal-title":"J. Proteome Res."},{"key":"2388_CR65","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.neo.2014.11.006","volume":"16","author":"R Mehra","year":"2014","unstructured":"Mehra, R. et al. A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer. Neoplasia 16, 1121\u20131127 (2014).","journal-title":"Neoplasia"},{"key":"2388_CR66","doi-asserted-by":"publisher","first-page":"e8816","DOI":"10.15252\/emmm.201708816","volume":"10","author":"MJ Schiewer","year":"2018","unstructured":"Schiewer, M. J. et al. PARP-1 regulates DNA repair factor availability. EMBO Mol. Med. 10, e8816 (2018).","journal-title":"EMBO Mol. Med."},{"key":"2388_CR67","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.molcel.2004.09.036","volume":"16","author":"B He","year":"2004","unstructured":"He, B. et al. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol. Cell 16, 425\u2013438 (2004).","journal-title":"Mol. Cell"},{"key":"2388_CR68","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1073\/pnas.0401123101","volume":"101","author":"PL Shaffer","year":"2004","unstructured":"Shaffer, P. L., Jivan, A., Dollins, D. E., Claessens, F. & Gewirth, D. T. Structural basis of androgen receptor binding to selective androgen response elements. Proc. Natl Acad. Sci. USA 101, 4758\u20134763 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2388_CR69","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"2388_CR70","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2144\/000112297","volume":"41","author":"P-Y Zeng","year":"2006","unstructured":"Zeng, P.-Y., Vakoc, C. R., Chen, Z.-C., Blobel, G. A. & Berger, S. L. In vivo dual cross-linking for identification of indirect DNA-associated proteins by chromatin immunoprecipitation. BioTechniques 41, 696\u2013698 (2006).","journal-title":"BioTechniques"},{"key":"2388_CR71","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1089\/cmb.2017.0096","volume":"24","author":"A Kechin","year":"2017","unstructured":"Kechin, A., Boyarskikh, U., Kel, A. & Filipenko, M. cutPrimers: a new tool for accurate cutting of primers from reads of targeted next generation sequencing. J. Comput. Biol. 24, 1138\u20131143 (2017).","journal-title":"J. Comput. Biol."},{"key":"2388_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"2388_CR73","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 47, e47 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2388_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2388_CR75","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s41556-024-01438-3","volume":"26","author":"M Zhang","year":"2024","unstructured":"Zhang, M. et al. Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression. Nat. Cell Biol. 26, 1176\u20131186 (2024).","journal-title":"Nat. Cell Biol."},{"key":"2388_CR76","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"2388_CR77","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. GigaScience 10, giab008 (2021).","journal-title":"GigaScience"},{"key":"2388_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45839-z","volume":"9","author":"HM Amemiya","year":"2019","unstructured":"Amemiya, H. M., Kundaje, A. & Boyle, A. P. The ENCODE blacklist: identification of problematic regions of the genome. Sci. Rep. 9, 9354 (2019).","journal-title":"Sci. Rep."},{"key":"2388_CR79","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"2388_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP\u2013Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"2388_CR81","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160\u2013W165 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2388_CR82","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"2388_CR83","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"2388_CR84","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces, M. R. et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat. Methods 14, 959\u2013962 (2017).","journal-title":"Nat. Methods"},{"key":"2388_CR85","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213\u20131218 (2013).","journal-title":"Nat. Methods"},{"key":"2388_CR86","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10\u201312 (2011).","journal-title":"EMBnet. J."},{"key":"2388_CR87","unstructured":"Andrews, S. FastQC: a quality control tool for high throughput sequence data. Babraham Bioinformatics http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/ (2010)."},{"key":"2388_CR88","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"2388_CR89","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"2388_CR90","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L.-G. & He, Q.-Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382\u20132383 (2015).","journal-title":"Bioinformatics"},{"key":"2388_CR91","doi-asserted-by":"publisher","first-page":"W202","DOI":"10.1093\/nar\/gkp335","volume":"37","author":"TL Bailey","year":"2009","unstructured":"Bailey, T. L. et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202\u2013W208 (2009).","journal-title":"Nucleic Acids Res."},{"key":"2388_CR92","doi-asserted-by":"crossref","first-page":"D87","DOI":"10.1093\/nar\/gkaa516","volume":"48","author":"O Fornes","year":"2020","unstructured":"Fornes, O. et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 48, D87\u2013D92 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2388_CR93","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1158\/0008-5472.CAN-24-0890","volume":"84","author":"R Shrestha","year":"2024","unstructured":"Shrestha, R. et al. An atlas of accessible chromatin in advanced prostate cancer reveals the epigenetic evolution during tumor progression. Cancer Res. 84, 3086\u20133100 (2024).","journal-title":"Cancer Res."},{"key":"2388_CR94","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida, W. et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc. Natl Acad. Sci. USA 116, 11428\u201311436 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2388_CR95","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data: Fig. 1. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"2388_CR96","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1\u2013pl1 (2013).","journal-title":"Sci. Signal."},{"key":"2388_CR97","unstructured":"Therneau, T. M. A Package for Survival Analysis in R. R version 3.8-4 https:\/\/cran.r-project.org\/package=survival (2024)."},{"key":"2388_CR98","unstructured":"Kassambara, A., Kosinski, M. & Biecek, P. Survminer: Drawing Survival Curves Using \u2018Ggplot2\u2019. R version 0.4.9 https:\/\/cran.r-project.org\/web\/packages\/survminer\/index.html (2021)."},{"key":"2388_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24919-7","volume":"12","author":"R Das","year":"2021","unstructured":"Das, R. et al. An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer. Nat. Commun. 12, 4601 (2021).","journal-title":"Nat. Commun."},{"key":"2388_CR100","doi-asserted-by":"publisher","unstructured":"Shrestha, R. Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator. Zenodo https:\/\/doi.org\/10.5281\/zenodo.15678437 (2025).","DOI":"10.5281\/zenodo.15678437"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02388-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02388-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02388-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T19:02:17Z","timestamp":1765393337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02388-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":100,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2388"],"URL":"https:\/\/doi.org\/10.1038\/s41588-025-02388-8","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, a note in the Author contributions indicating that Felix Y. Feng and Luke A. Gilbert (jointly supervising authors) may be listed in either order in any context was missing and is now amended in the HTML and PDF versions of the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.L., F.Y.F. and L.A.G. have filed a patent application related to targeting PTGES3. M.S. reports personal speaker fees from Astellas and consulting\/advisory board for Veracyte\/Adelphi Targis. J.C. has grant support from Amgen unrelated to this work. E.D. is an employee of Veracyte, makers of Decipher test. A.P.W. is a member of the Scientific Advisory Board and holds equity stakes in Indapta Therapeutics and Protocol Intelligence, LLC. P.S.N. has served as a paid consultant to Genentech, AstraZeneca, Pfizer and Janssen and received research support from Janssen for work unrelated to the present study. D.A.Q. has received consulting fees from Circle Pharma and Varian. K.M.S. has consulting agreements for the following companies involving cash and\/or stock compensation: Black Diamond Therapeutics, BridGene Biosciences, Denali Therapeutics, eFFECTOR Therapeutics, Erasca, Genentech\/Roche, Janssen Pharmaceuticals, Kumquat Biosciences, Kura Oncology, Merck, Mitokinin, Petra Pharma, Revolution Medicines, Type6 Therapeutics, Venthera, Wellspring Biosciences (Araxes Pharma). L.A.G. has filed patents on CRISPR functional genomics and is a cofounder of, and consults for, nChroma Bio. F.Y.F. consulted for Astellas, Bayer, Blue Earth Diagnostics, BMS, EMD Serono, Exact Sciences, Foundation Medicine, Janssen Oncology, Myovant, Roivant and Varian, and served on the Scientific Advisory Board for BlueStar Genomics and SerImmune. F.Y.F. has patent applications with Decipher Biosciences, as well as with PFS Genomics\/Exact Sciences in breast cancer, all unrelated to this work. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}